Physician profile
Johnson D Dellosa
NPI 1386696136
$751.59
in general payments reported to CMS, 2019-2025
18 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.11 · 2020: $183 · 2021: $54.47 · 2022: $73.68 · 2023: $52.87 · 2024: $97.50 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $106.84 | 2019-2025 | Zepbound, Mounjaro |
| Pfizer INC. | $103.60 | 2020-2025 | |
| Novo Nordisk INC | $87.24 | 2019-2025 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $59.58 | 2021-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.01 | 2020-2022 | |
| Shield Therapeutics INC | $53.43 | 2025 | |
| Abbvie INC. | $43.43 | 2023-2024 | Vraylar |
| Corcept Therapeutics | $38.35 | 2025 | Korlym |
| Amgen INC. | $35.92 | 2019-2024 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $23.82 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $23.66 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $22.42 | 2019 | |
| Exact Sciences Corporation | $20.40 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $17.31 | 2024 | Breztri |
| Allergan, INC. | $17.24 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.66 | 2023 | |
| Merck Sharp & Dohme LLC | $12.60 | 2020 | |
| Genentech USA, INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnson Dellosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.